# Aprea Therapeutics, Inc.: Form 8-K, filed Oct 23, 2024

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: 8-K
- Filed: 2024-10-23
- Accepted by EDGAR: Oct 23, 2024, 09:00 ET
- Period: 2024-10-23
- Accession: 0001558370-24-013486
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000155837024013486/apre-20241023x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000155837024013486/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000155837024013486/apre-20241023x8k.htm

Filed Oct 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-013486. Last ingested by Listed: Nov 4, 2026, 08:47 ET. No prices; not investment advice.